Login

Consolidated balance sheets

In millions of USD; shares in millions, except per-share amounts
Q2 FY2026
As of Jun 30, 2026
Q1 FY2026
As of Mar 31, 2026
Q4 FY2025
As of Dec 31, 2025
Q3 FY2025
As of Sep 30, 2025
Q2 FY2025
As of Jun 30, 2025
Q1 FY2025
As of Mar 31, 2025
Q4 FY2024
As of Dec 31, 2024
Q3 FY2024
As of Sep 30, 2024
Q2 FY2024
As of Jun 30, 2024
Q1 FY2024
As of Mar 31, 2024
Q4 FY2023
As of Dec 31, 2023
Q3 FY2023
As of Sep 30, 2023
Q2 FY2023
As of Jun 30, 2023
Q1 FY2023
As of Mar 31, 2023
Q4 FY2022
As of Dec 31, 2022
Q3 FY2022
As of Sep 30, 2022
Q2 FY2022
As of Jun 30, 2022
Q1 FY2022
As of Mar 31, 2022
Q4 FY2021
As of Dec 31, 2021
Q3 FY2021
As of Sep 30, 2021
Assets
Current assets:
Cash and cash equivalents
Accounts receivable (net of allowance for credit losses of $11 and $9 as of June 30, 2026 and December 31, 2025, respectively)
Total accounts receivable (net of allowance for credit losses of $11 and $9 as of June 30, 2026 and December 31, 2025, respectively)
Due from affiliates
Related Party
Total due from affiliates
Prepaid expenses and other current assets
Total current assets
Property and equipment, net
Equity method investments
Goodwill
Other intangible assets, net
Operating lease right-of-use assets
Deferred tax assets
Other non-current assets
Total assets
Liabilities and shareholders’ equity
Current liabilities:
Accounts payable
Total accounts payable
Due to affiliates
Related Party
Total due to affiliates
Accrued expenses and other current liabilities
Current portion of operating lease liabilities
Current portion of long-term debt
Total current liabilities
Long-term debt, net of unamortized debt discount and debt issuance costs
Deferred tax liabilities
Pension liabilities
Long-term operating lease liabilities
Earnout derivative liabilities
Other non-current liabilities
Total liabilities
Redeemable non-controlling interest
Shareholders’ equity:
Class A common stock (par value $0.0001; 3,000,000,000 shares authorized; 538,342,297 and 478,904,677 shares issued, 521,088,517 and 470,904,677 shares outstanding as of December 31, 2025 and December 31, 2024, respectively)
Class A common stock
Class B common stock
Total class A common stock (par value $0.0001; 3,000,000,000 shares authorized; 538,342,297 and 478,904,677 shares issued, 521,088,517 and 470,904,677 shares outstanding as of December 31, 2025 and December 31, 2024, respectively)
Class A common stock (par value $0.0001; 3,000,000,000 shares authorized; 547,016,649 and 538,342,297 shares issued, 522,285,480 and 521,088,517 shares outstanding as of June 30, 2026 and December 31, 2025, respectively)
Class A common stock
Total class A common stock (par value $0.0001; 3,000,000,000 shares authorized; 547,016,649 and 538,342,297 shares issued, 522,285,480 and 521,088,517 shares outstanding as of June 30, 2026 and December 31, 2025, respectively)
Additional paid-in capital
Accumulated deficit
Accumulated other comprehensive loss
Treasury shares, at cost (12,275,150 and 8,000,000 shares as of September 30, 2025 and December 31, 2024, respectively)
Treasury shares, at cost (24,731,169 and 17,253,780 shares as of June 30, 2026 and December 31, 2025, respectively)
Total equity of the Company’s shareholders
Equity attributable to non-controlling interest in subsidiaries
Total shareholders’ equity
Total liabilities, redeemable non-controlling interest and shareholders’ equity
Treasury shares, at cost (in shares)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support